Groundbreaking research reveals rheumatoid arthritis begins years before symptoms appear, opening new possibilities for prediction and prevention.
Discover how interferon-α creates therapeutic resistance in early rheumatoid arthritis through epigenetic reprogramming and what this means for personalized medicine.